A one-time stem cell transplantation therapy for multiple sclerosis showed improvements over the current treatment, according to a preliminary trial.
Northwestern was recently awarded a five-year, $13.5 million grant from the National Institutes of Health to create a platform of app-based tools, called the MobileToolbox, to remotely assess cognitive function.
Northwestern Medicine scientists have identified a gene, called isocitrate dehydrogenase 3-alpha, that promotes tumors in grade IV glioblastoma, according to a study published in Science Advances.
The ventral striatum, a small part of the brain’s basal ganglia, directs behavior by assigning a reward dimension to everyday items, according to a recent study.
The 8th Annual Les Turner Symposium brought together investigators, clinicians, patients and families to share the latest discoveries in ALS research, promote scientific collaboration and provide patient education.
A Northwestern University experimental therapeutic targeting a specific protein kinase reversed neurological symptoms in a mouse genetic model of autism, according to a recent Northwestern Medicine study.
Northwestern Medicine scientists have demonstrated that mitochondrial damage plays a critical early role in a group of diseases, including forms of ALS and dementia.
A new wireless, Band-Aid-like sensor developed at Northwestern University could revolutionize the way patients manage hydrocephalus — a potentially life-threatening condition in which excess fluid builds up in the brain.
Northwestern Medicine clinicians are at the forefront in using an advanced surgical treatment called deep brain stimulation to improve quality of life for patients with Parkinson’s and other movement disorders.
Northwestern Medicine scientists have discovered a mechanism for rapid, fine adjustments in motor plans, according to a recent study.